post operation pain. Acute pain due to trauma
Conditions
Interventions
Intervention group: Patients are divided into two groups. In the dexmedetomidine group, 4mg/kg of lidocaine and 1 micro/kg of dexmedetomidine will be used in the epinephrine syringe using distilled wa
Sponsors
Ahvaz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
20 Years to 60 Years
Inclusion criteria
Inclusion criteria: Patients between 20 and 60 years, ASA class 1,2
Exclusion criteria
Exclusion criteria: Allergy to the drugs used Diabetic patients Hypertension patients Coagulation abnormality Patients with heart disease Patients with spinal deformity
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain. Timepoint: 6-12-24-36-48hours after surgery. Method of measurement: After entering the operating room, they will be fully monitored, and ECG and NIBP and pulse oximetry will be installed for them, and their venous line will be placed with an angioket number 20 from the opposite hand, which is not the side of the operation. In both groups, before starting the block, patients will be sedated with 0.02 mg/kg of midazolam and 1 microgram/kg of fentanyl. In the dexmedetomidine group, 4mg/kg of lidocaine and 1 microgram/kg of dexmedetomidine will be used in the epinephrine syringe using distilled water to a total volume of 30cc. In the sufentanil group, 4 mg/kg of lidocaine and 0.1 micro/kg of sufentanil will be used in the epinephrine syringe using distilled water to a total volume of 30 cc. Patients will be placed under supraclavicular block by ultrasound method, and hemodynamic changes will be recorded every 15 minutes during the operation. During the operation, the patient's sedation level will be recorded using the Ramsay score. The amount of postoperative pain will also be recorded at 1, 2, 6, and 12 hours after the operation with VAS SCORE. | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood pressure and heart rate changes. Timepoint: Every 15 minutes during operation. Method of measurement: With pressure gauge and monitoring device. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Seyede fatemeh hosseninejad
Ahvaz University of Medical Sciences
Outcome results
None listed